Nanofiber & Filament-Based Nanocarriers: Advancing Precision Drug Delivery

Precision Drug Delivery

Once administered, drugs must navigate renal filtration, circulate in the bloodstream, and reach target cells. At the cellular level, therapeutic agents must breach the plasma membrane, survive intracellular degradation, and evade drug‑resistance mechanisms that malignant cells often employ. Nanomaterials—particularly filamentous nanocarriers—offer a promising strategy to overcome these barriers.

Nanocarrier Design

Traditional nanoparticle vehicles are typically spherical, yet elongated cylindrical particles can persist longer in circulation, enhancing tumor accumulation and facilitating cellular uptake. Researchers at the North‑Western Center for Nanomedicine Engineering (NWCCNE) have engineered self‑assembling nanofibers that fulfill these criteria.

Cylindrical Vehicles

By immersing peptide amphiphiles synthesized via automated solid‑phase peptide synthesis, the team induced spontaneous self‑assembly into micron‑long filaments. These filaments display a panel of biologically active peptides on their surface, enabling them to act simultaneously as therapeutic agents and delivery vehicles—eliminating the need for encapsulation of additional chemotherapeutics.

PEGylation and Enzymatic Stability

Attachment of polyethylene glycol (PEG) to the peptide amphiphile prolongs blood‑stream residence time. When a PEGylated amphiphile co‑assembles with the base amphiphile, the resulting nanofilament resists proteolytic degradation by trypsin, ensuring structural integrity until it reaches the target site.

Protein‑Based Nanofilaments

For cardiovascular and musculoskeletal disorders, the researchers incorporated micro‑protein aggregates that rapidly coalesce into nanofilaments. These structures are functionalized with vascular endothelial growth factor (VEGF) analogues, promoting angiogenesis and tissue regeneration in ischemic tissues and osteoarthritic cartilage.

Noodle‑Like Gel Nanofibers

In a separate study, the team fabricated “noodle gels”—thermoreversible nanofibers that transition into a noodle‑shaped gel upon heating, cooling, and extrusion into saline. These gels excel at delivering biologic cues, proteins, and stem cells to precise sites within the brain, heart, or spinal cord, and can be engineered to guide cell migration toward injury sites.

Collectively, these innovations demonstrate how nanofiber and filamentous platforms can enhance drug delivery, reduce off‑target effects, and ultimately improve patient outcomes across a spectrum of diseases.